Résultats de la recherche - 7 results
Characterisation and Hazard identification of substandard and Falsified Antimicrobial Drugs. The CantiBio project 2016-2020
antibiotics Quality risk analysis Abstract: Studies on SF antimicrobials, one of the most frequently used medical products, circulating in Europe or other industrialized regions are very scarce. However, case ...
Handbook of Solvents volume II, Use, Health and Environment
Publication Type: Scientific book or chapter Authors: Eric Deconinck; Bart Desmedt Source: Residual solvents in pharmaceutical substances and products, Volume 2, Issue 14.2, Number 1322, p.28 (2024) ...
The strategic change of the API fingerprint programme: from verification of authenticity of API sources to identifying potential quality issues
s and the detection of falsified or substandard ones, due to the risks related to the quality of the finished product. With this vision the fingerprint programme was created, where next to conformity ...
Accuracy of Labeling of Galantamine Generic Drugs and Dietary Supplements.
illégaux Illegale geneesmiddelen Service: Médicaments et produits de santé Geneesmiddelen en gezondheidsproducten Medicines and health products Pathogènes alimentaires Voedselpathogenen Foodborne pathogens ...
Substandard and falsified ivermectin tablets obtained for self-medication during the COVID-19 pandemic as a source of potential harm.
(n = 19) were compliant to the quality criteria applicable to medicinal products. These SF products either suffered from a systematic underdosing of the active pharmaceutical ingredient or were ...
Microbial quality analysis of falsified medicines seized by controling agencies
and weight loss aids. One of the driving forces behind the demand for these substandard and falsified products is their affordability, accessibility, and lack of prescription requirement, thereby ...
HPLC for Analysis of Substandard and Falsified Medicinal Products
Publication Type: Scientific book or chapter Authors: Eric Deconinck; Vanhee, Celine Source: HPLC for Analysis of Substandard and Falsified Medicinal Products, Elsevier, Issue 2, Number 75, ...